---
figid: PMC4156074__zbc0371492990001
figtitle: Activation cycle of the kallikrein-kinin enzymatic pathway
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Ovis aries
- Escherichia coli
- Escherichia coli IS1
- Escherichia coli IS5
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Dipturus trachyderma
- Macaca fascicularis
- Aphyosemion alpha
organisms_ner:
- Homo sapiens
- Mus musculus
pmcid: PMC4156074
filename: zbc0371492990001.jpg
figlink: /pmc/articles/PMC4156074/figure/F1/
number: F1
caption: Activation cycle of the kallikrein-kinin enzymatic pathway. Autoactivation
  of the proenzyme form of factor XII to XIIa (step 1) initiates a proteolytic cascade
  that activates pKal (step 2), which in turn cleaves HWMK to release bradykinin (step
  3) (in addition to the positive feedback activation of more FXII). Bradykinin subsequently
  binds and activates the bradykinin B2 receptor (step 4), thereby initiating an intracellular
  signaling cascade that ultimately results in swelling and pain in the affected tissues.
  Exoprotease activity on bradykinin generates des-Arg9bradykinin, which signals through
  the bradykinin B1 receptor (step 5). Individuals with HAE are deficient in C1-INH
  (step 6), the major inhibitor of active pKal and FXIIa, and subsequently exhibit
  unpredictable attacks of bradykinin-mediated pain and edema.
papertitle: Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking
  Antibody.
reftext: Jon A. Kenniston, et al. J Biol Chem. 2014 Aug 22;289(34):23596-23608.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.956816
figid_alias: PMC4156074__F1
figtype: Figure
redirect_from: /figures/PMC4156074__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4156074__zbc0371492990001.html
  '@type': Dataset
  description: Activation cycle of the kallikrein-kinin enzymatic pathway. Autoactivation
    of the proenzyme form of factor XII to XIIa (step 1) initiates a proteolytic cascade
    that activates pKal (step 2), which in turn cleaves HWMK to release bradykinin
    (step 3) (in addition to the positive feedback activation of more FXII). Bradykinin
    subsequently binds and activates the bradykinin B2 receptor (step 4), thereby
    initiating an intracellular signaling cascade that ultimately results in swelling
    and pain in the affected tissues. Exoprotease activity on bradykinin generates
    des-Arg9bradykinin, which signals through the bradykinin B1 receptor (step 5).
    Individuals with HAE are deficient in C1-INH (step 6), the major inhibitor of
    active pKal and FXIIa, and subsequently exhibit unpredictable attacks of bradykinin-mediated
    pain and edema.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SERPING1
  - KNG1
  - BDKRB1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - BDKRB2
  - F12
  - Serping1
  - Bdkrb1
  - Gpbar1
  - Bdkrb2
  - Bradykinin
---
